Têxtil Renauxview S.A. (BVMF:TXRX3)
9.98
+1.48 (17.41%)
At close: Jun 20, 2025
Têxtil Renauxview Income Statement
Financials in millions BRL. Fiscal year is January - December.
Millions BRL. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Revenue | 112.86 | 117.68 | 132.71 | 212.42 | 162.08 | 83.54 | Upgrade
|
| Revenue Growth (YoY) | -4.18% | -11.32% | -37.52% | 31.06% | 94.03% | -20.49% | Upgrade
|
| Cost of Revenue | 90.43 | 95.46 | 113.7 | 147.46 | 106.2 | 60.53 | Upgrade
|
| Gross Profit | 22.43 | 22.22 | 19.01 | 64.96 | 55.88 | 23.01 | Upgrade
|
| Selling, General & Admin | 30.77 | 26.92 | 29.69 | 33.56 | 26 | 20.79 | Upgrade
|
| Other Operating Expenses | 2.45 | -0.19 | -0.09 | -0.62 | -1.05 | -0.66 | Upgrade
|
| Operating Expenses | 33.21 | 26.73 | 29.6 | 32.95 | 24.96 | 20.13 | Upgrade
|
| Operating Income | -10.78 | -4.51 | -10.59 | 32.02 | 30.93 | 2.88 | Upgrade
|
| Interest Expense | -25.94 | -22.92 | -14.67 | -32.3 | -54.8 | -28.26 | Upgrade
|
| Interest & Investment Income | 0.08 | 0.04 | 0.18 | 1.42 | 0.12 | 6.64 | Upgrade
|
| Currency Exchange Gain (Loss) | 0.12 | -1.52 | -0.11 | - | 0.03 | - | Upgrade
|
| Other Non Operating Income (Expenses) | -20.84 | -21.18 | -16.11 | - | -0.67 | - | Upgrade
|
| EBT Excluding Unusual Items | -57.36 | -50.07 | -41.29 | 1.13 | -24.4 | -18.74 | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.71 | 0.71 | 0.02 | 0.05 | 0.01 | 0.01 | Upgrade
|
| Legal Settlements | -1.25 | - | - | - | 2.39 | - | Upgrade
|
| Other Unusual Items | 0.09 | 9.9 | 58.06 | -0.01 | 0.26 | 0.88 | Upgrade
|
| Pretax Income | -57.81 | -39.46 | 16.79 | 1.17 | -21.75 | -17.85 | Upgrade
|
| Income Tax Expense | 0.15 | -0.02 | 0.05 | 0.05 | 0.05 | 0.05 | Upgrade
|
| Net Income | -57.96 | -39.45 | 16.75 | 1.12 | -21.79 | -17.91 | Upgrade
|
| Net Income to Common | -57.96 | -39.45 | 16.75 | 1.12 | -21.79 | -17.91 | Upgrade
|
| Net Income Growth | - | - | 1391.10% | - | - | - | Upgrade
|
| Shares Outstanding (Basic) | 4 | 4 | 4 | 4 | 4 | 4 | Upgrade
|
| Shares Outstanding (Diluted) | 4 | 4 | 4 | 4 | 4 | 4 | Upgrade
|
| EPS (Basic) | -13.61 | -9.26 | 3.93 | 0.26 | -5.12 | -4.20 | Upgrade
|
| EPS (Diluted) | -13.61 | -9.26 | 3.93 | 0.26 | -5.12 | -4.20 | Upgrade
|
| EPS Growth | - | - | 1391.10% | - | - | - | Upgrade
|
| Gross Margin | 19.87% | 18.88% | 14.33% | 30.58% | 34.48% | 27.54% | Upgrade
|
| Operating Margin | -9.55% | -3.83% | -7.98% | 15.07% | 19.08% | 3.44% | Upgrade
|
| Profit Margin | -51.35% | -33.52% | 12.62% | 0.53% | -13.44% | -21.43% | Upgrade
|
| EBITDA | -6.47 | 0.17 | -8 | 36.97 | 35.86 | 8.68 | Upgrade
|
| EBITDA Margin | -5.74% | 0.15% | -6.03% | 17.41% | 22.13% | 10.39% | Upgrade
|
| D&A For EBITDA | 4.31 | 4.68 | 2.59 | 4.96 | 4.93 | 5.8 | Upgrade
|
| EBIT | -10.78 | -4.51 | -10.59 | 32.02 | 30.93 | 2.88 | Upgrade
|
| EBIT Margin | -9.55% | -3.83% | -7.98% | 15.07% | 19.08% | 3.44% | Upgrade
|
| Effective Tax Rate | - | - | 0.27% | 3.85% | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.